线粒体DNA拷贝数在静脉血栓栓塞症中的作用:一项两样本孟德尔随机化研究的启示
本研究采用两样本孟德尔随机化方法,利用大规模全基因组关联研究数据,探讨线粒体DNA拷贝数(mtDNA-CN)与静脉血栓栓塞症(VTE)、肺栓塞(PE)和深静脉血栓形成(DVT)的因果关系。结果显示遗传预测的mtDNA-CN对VTE、DVT和PE无显著因果效应(P=0.224、0.190、0.571),但遗传预测的VTE(OR=0.569)、PE(OR=0.991)和DVT(OR=0.429)与mtDNA-CN水平降低相关。结论提示VTE可能导致mtDNA-CN水平下降,mtDNA-CN或可作为VTE的临床生物标志物。
要点
- 遗传预测的mtDNA-CN对VTE、DVT和PE无显著因果效应(P值分别为0.224、0.190、0.571)。
- 遗传预测的VTE、PE和DVT与mtDNA-CN水平降低相关(OR分别为0.569、0.991、0.429)。
- 敏感性分析和重复分析证实了上述结果的稳健性。
核心结论
- 本研究结果不支持mtDNA-CN在VTE发生中的因果作用,但提供直接证据表明VTE可能导致mtDNA-CN水平降低。
- 这些结果提示mtDNA-CN可作为临床实践中VTE的生物标志物。
研究设计与样本
- 本研究为两样本孟德尔随机化分析,遗传工具变量来自最大的可用全基因组关联研究数据集,涉及VTE、PE和DVT。
- 主要分析方法为逆方差加权法,并进行敏感性分析以评估水平多效性和异质性,还利用mtDNA-CN的遗传工具变量进行了反向孟德尔随机化分析。
主要发现
- 遗传预测的mtDNA-CN水平对VTE(P=0.224)、DVT(P=0.190)和PE(P=0.571)无因果效应。
- 在逆方差加权分析中,遗传预测的VTE(OR=0.569,95%CI 0.341-0.952;P=0.032)、PE(OR=0.991,95%CI 0.983-0.999;P=0.037)和DVT(OR=0.429,95%CI 0.207-0.890;P=0.023)与mtDNA-CN水平降低相关。
- 敏感性和重复分析证实了这些发现的稳健性。
临床怎么用
- 作者认为mtDNA-CN可作为临床实践中VTE的生物标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), is the third most common cardiovascular disease. A low amount of mitochondrial DNA copy number (mtDNA-CN) reflects mitochondrial dysfunctions and has been associations with arterial cardiovascular diseases. However, the role of mtDNA-CN in venous cardiovascular disease was unclear. We aimed to implement a 2-sample Mendelian randomization analysis to approximate the causal nature of these relationships. METHODS: Genetic instruments for VTE, PE, and DVT were derived from the largest available genome-wide association study datasets. The inverse variance weighted method was used as the primary analytical approach, with sensitivity analyses performed to assess horizontal pleiotropy and heterogeneity. The reverse Mendelian randomization analysis was conducted using genetic instruments for mtDNA-CN. RESULTS: The genetically instrumented mtDNA-CN levels did not exhibit a causal effect on VTE (P = 0.224), DVT (P = 0.190), and PE (P = 0.571). However, genetically predicted VTE (odds ratio (OR) = 0.569, 95% confidence interval (CI) = 0.341-0.952; P = 0.032), PE (OR = 0.991, 95% CI = 0.983-0.999; P = 0.037), and DVT (OR = 0.429, 95% CI = 0.207-0.890; P = 0.023) were associated with decreased mtDNA-CN levels in the inverse variance weighted analysis. Sensitivity and replication analyses confirmed the robustness of these findings. CONCLUSION: Our findings did not support a causal effect of mtDNA-CN in the development of VTE, but provide direct evidence that VTE may lead to reduced mtDNA-CN levels. These results suggest that mtDNA-CN as a biomarker of VTE in clinical practice.
引用
- Xiang C, Zheng M, Li Y, et al. The Role of Mitochondrial DNA Copy Number in Venous Thromboembolism: Insights from a 2-Sample Mendelian Randomization Study. Ann Vasc Surg. 2025. PMID: 40074369. doi:10.1016/j.avsg.2025.01.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。